Phase I/II Clinical Study of 1A46 Drug Substance

NCT05987605 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

4

Enrollment

INDUSTRY

Sponsor class

Stopped sponsor's Research and Development strategy adjustment

Conditions

Advanced Malignancies

Interventions

DRUG: 1A46 Drug Substance

Sponsor

BioRay Pharmaceutical Co., Ltd.